Identification of LASSBio-1945 as an inhibitor of SARS-CoV-2 main protease (MPRO) through in silico screening supported

molecular docking and a fragment-based pharmacophore model

★ 5.0 · 62 reads

Sign in to save this
Request Code
ZLIB.IO18508618
Published
2022
Pages
1
Language
Unknown